Anti-Human C5 Recombinant Antibody(Ravulizumab)

Product Information

Catalog Number	YR1443
Product Name	Anti-Human C5 Recombinant Antibody(Ravulizumab)
Molecular Name	Ravulizumab
Alias	Anti-C5 Recombinant Antibody, Research Grade Ravulizumab
CAS Number	1803171-55-2
Target	C5[Homo sapiens]
Isotype	IgG2-G4 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Buffer	PBS, pH7.5
Background	Ravulizumab, sold under the brand name Ultomiris, is a humanized monoclonal antibody complement inhibitor medication designed for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome. It is designed to bind to and prevent the activation of Complement component 5 (C5).
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price